In 2011, the FDA cleared I-123 ioflupane for dopamine transporter imaging, and an SNM expert provides coding advice for Parkinsonian syndromes.

Advancements in molecular neuroimaging are providing new ways to assess neuroinflammation in the brain.

With the aging population, the proliferation of neurodegenerative diseases, particularly Alzheimers, is becoming a truly global burden.

Carestream received U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System, and is now available in the U.S., along with Europe and Canada.

Acting on orders from the FDA, federal marshals siezed a quantity of ultrasound transmission gel from its New Jersey manufacturer after the product was found to have been tainted with dangerous bacteria.

A study published in the journal Cancer linking bitewing dental x-rays with brain tumors has drawn as much flak for its methodology as it has publicity for its results.

Summa Health System (Akron, Ohio), one of the largest health-care networks in the state, was facing a difficulty common to organizations that provide imaging for bariatric patients: the 0.3T open MRI system at its Summa Health Center at White Pond, to which many of these patients had to be referred, was too low in field strength for certain types

Legislative efforts to require information about breast density on mammography results provided to patients have raised awareness about the varying effectiveness of mammography. However, up until recently, there has been little data on what, if anything, women with dense breast tissue should do to improve their odds of early detection of breast